The pathology of human bladder cancer

Breast cancer action plan for Kentucky.

The Journal of the Kentucky Medical Association·2001

Improving comprehension for cancer patients with low literacy skills: strategies for clinicians.

CA: a cancer journal for clinicians·1998

What providers should know about community cancer control.

Cancer practice·1997

False negative rate. A misnomer, misunderstood and misused.

Acta cytologica·1997

Sample size calculations for rescreening cytologic smears.

Acta cytologica·1996

Are the known bladder cancer risk-factors associated with more advanced bladder cancer?

Cancer causes & control : CCC·1993

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Cancer·2026

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

Cancer·2026

Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis.

Cancer·2026

The past, present, and future treatment of BRAFV600-mutant metastatic colorectal cancer: A comprehensive review.

Cancer·2026

Patient navigation as a core component of global cancer care-A call to action from the Global Alliance for Cancer Patient Navigation.

Cancer·2026

The American Cancer Society National Lung Cancer Roundtable strategic plan: Opportunities in advanced imaging across the lung cancer care continuum.

Cancer·2026

Imbalanced p53-RB signaling triggers cGAS-STING-mediated immune activation in early oral cancer development.

Oncogene·2026

Research advances in the recurrence patterns of glioblastoma.

Biochimica et biophysica acta. Reviews on cancer·2026

IGF2BP3 promotes esophageal squamous cell carcinoma progression by regulating global protein translation.

Biochimica et biophysica acta. Molecular basis of disease·2026

Progress in Hydroxyapatite Nanocarriers for Targeted and Enhanced Osteoporosis Treatment: A Comprehensive Review.

Molecular biotechnology·2026

ATF4 and FGFR4 cooperatively support thyroid cancer progression and CAF-associated tumor-promoting features.

Endocrine·2026

DLL3 serves as a pivotal hub bridging malignant progression and immunosuppression in NECC with therapeutic implications validated via the organoid-TIL co-culture system.

Genes & diseases·2026

Related Experiment Videos

The pathology of human bladder cancer

Related Concept Videos

Breast cancer action plan for Kentucky.

Improving comprehension for cancer patients with low literacy skills: strategies for clinicians.

What providers should know about community cancer control.

False negative rate. A misnomer, misunderstood and misused.

Sample size calculations for rescreening cytologic smears.

Are the known bladder cancer risk-factors associated with more advanced bladder cancer?

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis.

The past, present, and future treatment of BRAFV600-mutant metastatic colorectal cancer: A comprehensive review.

Patient navigation as a core component of global cancer care-A call to action from the Global Alliance for Cancer Patient Navigation.

The American Cancer Society National Lung Cancer Roundtable strategic plan: Opportunities in advanced imaging across the lung cancer care continuum.

Imbalanced p53-RB signaling triggers cGAS-STING-mediated immune activation in early oral cancer development.

Research advances in the recurrence patterns of glioblastoma.

IGF2BP3 promotes esophageal squamous cell carcinoma progression by regulating global protein translation.

Progress in Hydroxyapatite Nanocarriers for Targeted and Enhanced Osteoporosis Treatment: A Comprehensive Review.

ATF4 and FGFR4 cooperatively support thyroid cancer progression and CAF-associated tumor-promoting features.

DLL3 serves as a pivotal hub bridging malignant progression and immunosuppression in NECC with therapeutic implications validated via the organoid-TIL co-culture system.

Related Experiment Videos

The pathology of human bladder cancer

Related Concept Videos

Related Articles